Capstone Therapeutics Corp.
CAPS Basic Materials Building Materials
Capstone Therapeutics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $46.9 million, up 4.47% from fiscal 2024. In the quarter to June 2026, revenue grew 67.1%, EPS grew 15.4%, free cash flow grew 73.4% and total debt rose 45.9%, each against the same quarter a year earlier.
Follow CAPS
Capstone Therapeutics Corp. (CAPS) Piotroski F-score
Capstone Therapeutics Corp.'s Piotroski F-score for fiscal 2025 is 3 out of 9: 3 of nine tests of profitability, leverage and efficiency passed.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 3 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (44.49%) | (11.00%) | Fail | 0 |
| Positive operating cash flow | (4.41m) | 3.87m | Fail | 0 |
| Rising return on assets | (44.49%) | (11.00%) | Fail | 0 |
| Cash flow above net income | 17.52m | 9.36m | Pass | 1 |
| Falling long-term leverage | 0.19 | 0.13 | Fail | 0 |
| Rising current ratio | 1.00 | 1.02 | Fail | 0 |
| No new shares issued | 5,321,500 | 157,600 | Fail | 0 |
| Rising gross margin | 23.02% | 21.33% | Pass | 1 |
| Rising asset turnover | 0.95 | 0.90 | Pass | 1 |
| Piotroski F-score | Weak — most fundamentals deteriorated | 3 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| CPAC Cementos Pacasmayo S.A.A. compare | 7 |
| SMID Smith-Midland Corp. compare | 7 |
| TTAM Titan America SA compare | 6 |
| LOMA Loma Negra Compania Industrial Argentina S.A. Sponsored ADR compare | 5 |
| TGLS Tecnoglass Holdings Inc. compare | 4 |
| CAPS Capstone Therapeutics Corp. | 3 |
| RETO ReTo Eco-Solutions, Inc. compare | 2 |
| CPTAF Captivision Inc. compare | — |
| RMIX Suncrete, Inc. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover